Form 8-K

CARDIOVASCULAR SYSTEMS, INC.

/s/ Laurence L. Betterley

Laurence L. Betterley

Chief Financial Officer

0001193125-11-284162.txt : 20111027 0001193125-11-284162.hdr.sgml : 20111027 20111027161634 ACCESSION NUMBER: 0001193125-11-284162 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111025 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20111027 DATE AS OF CHANGE: 20111027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 111162082 BUSINESS ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 8-K 1 d248338d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 25, 2011

Cardiovascular Systems, Inc.

(Exact name of Registrant as Specified in its Charter)

Delaware

000-52082

41-1698056

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

651 Campus Drive

St. Paul, Minnesota 55112-3495

(Address of Principal Executive Offices and Zip Code)

(651) 259-1600

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07

Submission of Matters to a Vote of Security Holders

Cardiovascular Systems, Inc. (the “Company”) held its 2011 Annual Meeting of Stockholders on October 25, 2011. Set forth below is a brief description of each matter voted upon at the meeting and the voting results with respect to each matter.

1.	A proposal to elect Class III directors to hold office until the fiscal 2014 Annual Meeting of Stockholders:


Class III Director’s Name	Votes For		Votes Withheld		Broker Non-Votes
Geoffrey O. Hartzler, M.D.		8,786,549		398,111		4,605,599
David L. Martin		8,648,449		536,211		4,605,599
Glen D. Nelson, M.D.		8,714,492		470,168		4,605,599

2.	A proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending June 30, 2012:


For	Against		Abstain
13,768,975		12,943		8,341

3.	A proposal to cast a non-binding advisory vote on the compensation paid to the Company’s named executive officers in fiscal 2011:


For	Against		Abstain		Broker Non-Votes
8,669,604		500,669		14,387		4,605,599

4.	A proposal to cast a non-binding advisory vote on the frequency of non-binding advisory votes on the compensation of the Company’s named executive officers:


1 Year	2 Years		3 Years		Abstain		Broker Non-Votes
5,673,075		20,341		3,473,614		17,630		4,605,599

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 27, 2011